Rekombinanter SELP (Inclacumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter SELP (Inclacumab Biosimilar) Antikörper (ABIN7597746)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Research Grade Inclacumab Biosimilar Antibody
-
Spezifität
- Leukocyte-endothelial cell adhesion molecule 3, Platelet activation dependent granule-external membrane protein, Granule membrane protein 140, GMP-140, CD62P, SELP, GRMP, PADGEM, CD62 antigen-like family member P, LECAM3, P-selectin, GMRP
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG4 kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.68 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Haltbarkeit
- 12 months
-
-
- SELP (Inclacumab Biosimilar)
-
Andere Bezeichnung
- Inclacumab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
- Leukocyte-endothelial cell adhesion molecule 3, Platelet activation dependent granule-external membrane protein, Granule membrane protein 140, GMP-140, CD62P, SELP, GRMP, PADGEM, CD62 antigen-like family member P, LECAM3, P-selectin, GMRP
-
UniProt
- P16109
-
CAS-Nummer
- 1256258-86-2
Target
-